Treatment of Compulsive Hoarding
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00073346|
Recruitment Status : Completed
First Posted : November 21, 2003
Last Update Posted : June 20, 2013
|Condition or disease||Intervention/treatment||Phase|
|Obsessive-Compulsive Disorder||Behavioral: Cognitive Behavioral Treatment||Phase 1|
Compulsive hoarding is a form of obsessive-compulsive disorder (OCD) that is characterized by excessive acquisition of possessions, difficulty discarding possessions, and excessive clutter. This condition is resistant to both pharmacological and psychotherapeutic interventions that are effective in treating other symptoms of OCD. This study will determine the effectiveness of cognitive behavioral therapy (CBT) in treating compulsive hoarding symptoms.
This study consists of three phases. In Phase 1, data from previously conducted pilot studies will be revised and expanded. In Phase 2, the revised data will be used to develop and implement a treatment manual for compulsive hoarding. During this phase, treatment will be flexibly applied to allow for variations in treatment duration and choice of techniques. During Phase 3, participants will be randomly assigned to either CBT or a wait-list control, followed by active treatment for a fixed duration. Therapist adherence and competence will be assessed through audiotaped therapy sessions.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||52 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Treatment of Compulsive Hoarding|
|Study Start Date :||September 2003|
|Estimated Study Completion Date :||August 2006|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00073346
|United States, Connecticut|
|Hartford Hospital, Institute of Living|
|Hartford, Connecticut, United States, 06106|
|United States, Massachusetts|
|Boston, Massachusetts, United States, 02215|